BioRem Statistics

Total Valuation

BioRem has a market cap or net worth of CAD 29.51 million. The enterprise value is 23.28 million.

Market Cap	29.51M
Enterprise Value	23.28M

Important Dates

The last earnings date was Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	n/a

Share Statistics

BioRem has 15.70 million shares outstanding. The number of shares has increased by 1.38% in one year.

Current Share Class	15.70M
Shares Outstanding	15.70M
Shares Change (YoY)	+1.38%
Shares Change (QoQ)	+18.67%
Owned by Insiders (%)	1.99%
Owned by Institutions (%)	n/a
Float	15.39M

Valuation Ratios

The trailing PE ratio is 14.00.

PE Ratio	14.00
Forward PE	n/a
PS Ratio	0.81
PB Ratio	2.76
P/TBV Ratio	2.76
P/FCF Ratio	7.19
P/OCF Ratio	7.02
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.17, with an EV/FCF ratio of 5.67.

EV / Earnings	8.51
EV / Sales	0.64
EV / EBITDA	5.17
EV / EBIT	5.86
EV / FCF	5.67

Financial Position

The company has a current ratio of 1.65, with a Debt / Equity ratio of 0.32.

Current Ratio	1.65
Quick Ratio	1.29
Debt / Equity	0.32
Debt / EBITDA	0.75
Debt / FCF	0.82
Interest Coverage	21.19

Financial Efficiency

Return on equity (ROE) is 30.30% and return on invested capital (ROIC) is 19.49%.

Return on Equity (ROE)	30.30%
Return on Assets (ROA)	9.88%
Return on Invested Capital (ROIC)	19.49%
Return on Capital Employed (ROCE)	29.66%
Revenue Per Employee	1.07M
Profits Per Employee	80,494
Employee Count	34
Asset Turnover	1.44
Inventory Turnover	11.95

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.05% in the last 52 weeks. The beta is 0.77, so BioRem's price volatility has been lower than the market average.

Beta (5Y)	0.77
52-Week Price Change	-1.05%
50-Day Moving Average	2.08
200-Day Moving Average	2.54
Relative Strength Index (RSI)	42.85
Average Volume (20 Days)	70,972

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioRem had revenue of CAD 36.23 million and earned 2.74 million in profits. Earnings per share was 0.13.

Revenue	36.23M
Gross Profit	9.39M
Operating Income	3.97M
Pretax Income	3.73M
Net Income	2.74M
EBITDA	4.31M
EBIT	3.97M
Earnings Per Share (EPS)	0.13

Full Income Statement

Balance Sheet

The company has 9.60 million in cash and 3.37 million in debt, giving a net cash position of 6.23 million or 0.40 per share.

Cash & Cash Equivalents	9.60M
Total Debt	3.37M
Net Cash	6.23M
Net Cash Per Share	0.40
Equity (Book Value)	10.69M
Book Value Per Share	0.58
Working Capital	9.62M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.20 million and capital expenditures -99,727, giving a free cash flow of 4.10 million.

Operating Cash Flow	4.20M
Capital Expenditures	-99,727
Free Cash Flow	4.10M
FCF Per Share	0.26

Full Cash Flow Statement

Margins

Gross margin is 25.91%, with operating and profit margins of 10.96% and 7.55%.

Gross Margin	25.91%
Operating Margin	10.96%
Pretax Margin	10.31%
Profit Margin	7.55%
EBITDA Margin	11.91%
EBIT Margin	10.96%
FCF Margin	11.32%

Dividends & Yields

BioRem does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.38%
Shareholder Yield	n/a
Earnings Yield	9.27%
FCF Yield	13.90%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a